A prospective cohort study to evaluate the incidence of febrile neutropenia in patients receiving pegfilgrastim on-body injector versus other options for prophylaxis of febrile neutropenia: breast cancer subgroup analysis

Publication Date

7-2022

Content Type

Article

PubMed ID:

35426046

Additional Authors:

Additional authors and institutional affiliations

This document is currently not available here.

Share

COinS